The recent incorporation of medium chain acyl-CoA dehydrogenase deficiency (MCADD) in newborn screening programs has facilitated the expansion of epidemiologic knowledge of this treatable disorder.

"Dr. Rahul Banerjee joins the podcast to discuss the latest update to the living guideline on the treatment of multiple myeloma. He explains how sensational results from the MajesTEC-3 trial, which ...

Frontier survey of embodied AI: VLN, VLA/WAM, agentic planning, lightweight deployment, and autonomous robot decision-making. - neardws/awesome-embodied-ai-papers ...